Solux Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.034x

Solux Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Solux Co. Ltd (290690) has a cash flow conversion efficiency ratio of 0.034x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.85 Billion ≈ $2.61 Million USD) by net assets (₩113.55 Billion ≈ $76.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Solux Co. Ltd (2018–2025)

Cash flow conversion efficiency of Solux Co. Ltd from 2018 to 2025. This chart illustrates how Solux Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Solux Co. Ltd (290690) share price today for real-time trading data and today's change.

Solux Co. Ltd Cash Flow Conversion Ratio Explained

Solux Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Solux Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Solux Co. Ltd ranked by their cash flow conversion efficiency. Also see 290690 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
TMT Steel Public Company Limited BK:TMT	0.160x
T.K.S. Technologies Public Company Limited BK:TKS	0.027x
WW International, Inc. Common Stock NASDAQ:WW	-0.010x
Awardit AB ST:AWRD	-0.008x
Dongkuk Industries Co. Ltd KQ:005160	0.085x
Shanghai Haixin Group Co Ltd B SHG:900917	0.001x
Bioxyne Ltd AU:BXN	-0.064x
Maywood Acquisition Corp. Class A Ordinary Shares NASDAQ:MAYA	-0.002x

Annual Cash Flow Conversion Efficiency for Solux Co. Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Solux Co. Ltd from 2018 to 2025. Review 290690 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩90.89 Billion ≈ $61.60 Million	₩-2.70 Billion ≈ $-1.83 Million	-0.030x	+63.92%
2024-12-31	₩78.33 Billion ≈ $53.09 Million	₩-6.45 Billion ≈ $-4.37 Million	-0.082x	-40.38%
2023-12-31	₩62.42 Billion ≈ $42.30 Million	₩-3.66 Billion ≈ $-2.48 Million	-0.059x	-116.22%
2022-12-31	₩43.34 Billion ≈ $29.37 Million	₩15.68 Billion ≈ $10.62 Million	0.362x	+373.45%
2021-12-31	₩47.94 Billion ≈ $32.49 Million	₩-6.34 Billion ≈ $-4.30 Million	-0.132x	-141.85%
2020-12-31	₩43.01 Billion ≈ $29.15 Million	₩-2.35 Billion ≈ $-1.59 Million	-0.055x	-139.26%
2019-12-31	₩20.30 Billion ≈ $13.76 Million	₩2.83 Billion ≈ $1.92 Million	0.139x	-84.58%
2018-12-31	₩14.71 Billion ≈ $9.97 Million	₩13.29 Billion ≈ $9.00 Million	0.903x	--

About Solux Co. Ltd

KQ:290690 Korea Biotechnology

Market Cap

$121.02 Million

₩178.58 Billion KRW

Market Cap Rank

#18289 Global

#805 in Korea

Share Price

₩3620.00

Change (1 day)

+29.98%

52-Week Range

₩2620.00 - ₩6020.00

All Time High

₩34400.00